6.11
+0.21(+3.56%)
Currency In USD
Address
4851 Tamiami Trail North
Naples, FL 34103
United States of America
Phone
239 302 1707
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
May 04, 2015
| Name | Title | Pay | Year Born |
| Dr. Joseph Edward Tucker Ph.D. | Chief Executive Officer & Director | 458,640 | 1968 |
| Dr. Peter J. Facchini Ph.D. | Chief Innovation Officer | 215,269 | 1963 |
| Mr. Kevin M. Coveney CPA | Chief Financial Officer | 385,000 | 1964 |
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.